|
US3236730A
(en)
|
1962-01-04 |
1966-02-22 |
Miles Lab |
Blepharitis composition comprising antiseptic, quaternary ammonium compound, keratolytic agent and a chelating compound
|
|
US5602130A
(en)
|
1987-03-20 |
1997-02-11 |
Allergan |
Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
|
|
JP2891883B2
(ja)
*
|
1993-11-05 |
1999-05-17 |
学校法人近畿大学 |
抗白内障医薬組成物
|
|
WO1997020578A1
(en)
*
|
1995-12-04 |
1997-06-12 |
University Of Miami |
Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
|
|
US5965606A
(en)
|
1995-12-29 |
1999-10-12 |
Allergan Sales, Inc. |
Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
|
|
EP0930072A1
(en)
|
1998-01-13 |
1999-07-21 |
Kartar Dr. Lalvani |
Vitamin and mineral containing compositions for the treatment of dry eye
|
|
US6348508B1
(en)
|
2000-04-04 |
2002-02-19 |
Bausch & Lomb Incorporated |
Method for treating dry eye
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
CA2463975A1
(en)
|
2001-10-26 |
2003-05-01 |
Maria Emilia Di Francesco |
Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
|
|
FR2833268B1
(fr)
|
2001-12-12 |
2005-07-08 |
Fabre Pierre Dermo Cosmetique |
Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation
|
|
KR100564386B1
(ko)
|
2002-05-13 |
2006-03-27 |
주식회사 마이코플러스 |
4-하이드록시-5-메톡시-4-[2-메틸-3-(3-메틸-2-부테닐)-2-옥시란닐]-1-옥사스피로[2,5]옥탄-6-온을 함유한 지루치료용 약제학적 조성물
|
|
US8420699B1
(en)
*
|
2002-06-19 |
2013-04-16 |
Irvine L. Dubow |
Composition and methods of treatment using deionized and ozonated solution
|
|
CN101897662B
(zh)
|
2002-07-23 |
2013-05-22 |
诺瓦提斯公司 |
包含药物、软膏基质和增溶剂/分散剂的眼用软膏剂组合物
|
|
EP2272340B1
(en)
|
2002-08-19 |
2018-03-14 |
Ira Sanders |
Botulinum toxin
|
|
US20040171561A1
(en)
|
2002-09-03 |
2004-09-02 |
Popp Karl F. |
Topical formulations for treatment of rosacea
|
|
US7795203B2
(en)
|
2002-09-30 |
2010-09-14 |
Babizhayev Mark A |
Method for topical treatment of eye disease and composition and device for said treatment
|
|
US20060188471A1
(en)
|
2002-10-31 |
2006-08-24 |
Podolsky Daniel K |
Methods of treating epithelial lesions
|
|
GB0225795D0
(en)
|
2002-11-05 |
2002-12-11 |
Guillon Michael |
Wipes
|
|
US20070269537A1
(en)
|
2003-02-10 |
2007-11-22 |
Bioderm Research |
Skin Condition Improvement Including Acne, Rosacea, and Topical Wounds by Artemisia Annua Extract via Iron Siderophore Trojan Horse Delivery System
|
|
GB0322448D0
(en)
|
2003-09-25 |
2003-10-29 |
Lamellar Therapeutics Ltd |
Using lamellar bodies to modify linear biological macro molecules
|
|
US20050197614A1
(en)
|
2004-03-04 |
2005-09-08 |
Wilson Pritchard |
Occlusive biomedical devices, punctum plugs, and methods of use thereof
|
|
US20050202097A1
(en)
|
2004-03-12 |
2005-09-15 |
Melbj Holdings, Llc, Florida |
Lubricant for the ocular surface
|
|
US8455016B2
(en)
|
2004-03-12 |
2013-06-04 |
Melbj Holdings, Llc |
Treatment for meibomian gland dysfunction or obstruction
|
|
EP1621191A1
(en)
|
2004-07-29 |
2006-02-01 |
Werner Bollag |
Treatment of inflammatory diseases by RXR Antagonists
|
|
US20090214676A1
(en)
|
2005-04-30 |
2009-08-27 |
Tissuetech, Inc. |
Method for treating ocular demodex
|
|
AU2006260184B2
(en)
*
|
2005-06-22 |
2011-05-12 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Prophylactic or therapeutic agent for corneal/conjunctival disease
|
|
WO2013003594A2
(en)
|
2011-06-28 |
2013-01-03 |
Tearscience, Inc. |
Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
|
|
US8083787B2
(en)
|
2005-07-18 |
2011-12-27 |
Tearscience, Inc. |
Method and apparatus for treating meibomian gland dysfunction
|
|
US7981095B2
(en)
|
2005-07-18 |
2011-07-19 |
Tearscience, Inc. |
Methods for treating meibomian gland dysfunction employing fluid jet
|
|
WO2007070463A2
(en)
*
|
2005-12-12 |
2007-06-21 |
Riolan Technologies, Inc. |
Compositions, methods and kits for removing debris from an ocular area
|
|
WO2007133703A2
(en)
|
2006-05-10 |
2007-11-22 |
Dxterity Diagnostics |
Detection of nucleic acid targets using chemically reactive oligonucleotide probes
|
|
US8568790B2
(en)
|
2006-05-31 |
2013-10-29 |
Medihoney Pty Ltd. |
Medicinal compositions containing honey
|
|
WO2008027069A1
(en)
|
2006-08-21 |
2008-03-06 |
Tearscience, Inc. |
Method and apparatus for treating meibomian gland dysfunction employing fluid
|
|
US8249695B2
(en)
|
2006-09-29 |
2012-08-21 |
Tearscience, Inc. |
Meibomian gland imaging
|
|
US8090426B2
(en)
|
2006-10-27 |
2012-01-03 |
Felder Robin A |
Microelectronic biosensor plug
|
|
WO2008058034A1
(en)
|
2006-11-03 |
2008-05-15 |
Qlt Inc. |
Methods of treating dermatological disorders or conditions
|
|
WO2008068866A1
(en)
*
|
2006-11-30 |
2008-06-12 |
Menicon Co., Ltd. |
Ophthalmic composition
|
|
US20080312194A1
(en)
*
|
2007-02-28 |
2008-12-18 |
Ousler Iii George W |
Methods and compositions for normalizing meibomian gland secretions
|
|
US8128968B2
(en)
|
2007-08-29 |
2012-03-06 |
Tissuetech, Inc. |
Compositions and methods for treating Demodex infestations
|
|
JP5668476B2
(ja)
|
2007-10-08 |
2015-02-12 |
オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． |
カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物
|
|
US20110059925A1
(en)
*
|
2008-03-26 |
2011-03-10 |
Eric Donnenfeld |
Methods for improving lid margin and tear film function and treatment of lid margin disease using tetracycline family antibiotics
|
|
JP5552482B2
(ja)
|
2008-04-30 |
2014-07-16 |
キュー エル ティー インク． |
複合涙管挿入物および関連する方法
|
|
US8716238B2
(en)
|
2008-07-10 |
2014-05-06 |
Allergan, Inc. |
Cyclosporin derivatives for treating ocular and dermal diseases and conditions
|
|
WO2010033800A2
(en)
|
2008-09-19 |
2010-03-25 |
Alacrity Biosciences, Inc. |
Tetracycline stabilizing formulations
|
|
DK2424374T3
(en)
|
2009-05-01 |
2018-05-07 |
Advanced Vision Res Inc |
Detergent compositions and methods for using the same
|
|
CN101612161A
(zh)
|
2009-08-07 |
2009-12-30 |
魏谠全 |
一种眼药组合物及其制剂
|
|
ES2752008T3
(es)
*
|
2009-10-30 |
2020-04-02 |
Intratus Inc |
Métodos y composiciones para la liberación sostenida de fármacos
|
|
WO2011068786A2
(en)
|
2009-12-02 |
2011-06-09 |
Bridge Pharma, Inc. |
Treating xerophthalmia with compounds increasing meibomian gland secretion
|
|
US20120093876A1
(en)
|
2010-10-13 |
2012-04-19 |
Aciex, Inc. |
Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions
|
|
CN104758921A
(zh)
|
2010-11-08 |
2015-07-08 |
希尔洛有限公司 |
缓冲的眼用组合物以及使用其的方法
|
|
WO2012092375A1
(en)
|
2010-12-29 |
2012-07-05 |
Inspire Pharmaceuticals, Inc. |
Method for treating dry eye
|
|
JP5952302B2
(ja)
|
2010-12-29 |
2016-07-13 |
ニチャミン、ルイス・ディー |
眼の治療のための方法及びキット
|
|
WO2012092378A1
(en)
|
2010-12-29 |
2012-07-05 |
Inspire Pharmaceuticals, Inc. |
Method for treating blepharitis
|
|
AU2012209184B2
(en)
|
2011-01-26 |
2017-06-15 |
Allergan, Inc. |
Androgen composition for treating an opthalmic condition
|
|
CN103998464A
(zh)
|
2011-05-20 |
2014-08-20 |
学校法人庆应义塾 |
新型金属蛋白质及其制造方法以及含有所述金属蛋白质的角结膜疾病的预防或治疗剂
|
|
WO2013003731A2
(en)
|
2011-06-29 |
2013-01-03 |
Insite Vision Incorporated |
Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence
|
|
ITFI20120044A1
(it)
|
2012-03-01 |
2013-09-02 |
Biodue Spa |
Formulazione ad uso oftalmico comprendente olio di jojoba.
|
|
CN104254339B
(zh)
*
|
2012-04-16 |
2020-01-21 |
路博润高级材料公司 |
用于治疗和/或护理皮肤和/或粘膜的化合物和它们在化妆品组合物或药物组合物中的用途
|
|
CA2888647A1
(en)
*
|
2012-11-20 |
2014-05-30 |
Revive Therapeutics Inc. |
The use of bucillamine in the treatment of gout
|
|
US9211397B2
(en)
*
|
2012-12-19 |
2015-12-15 |
Senju Usa, Inc. |
Patch for treatment of eyelid disease containing clobetasol
|
|
US9987235B2
(en)
*
|
2013-08-01 |
2018-06-05 |
Nicholas L. Abbott |
Methods and compositions for modifying mucous membranes
|
|
HUE14755117T2
(hu)
|
2013-08-14 |
2018-12-28 |
Kalvista Pharmaceuticals Ltd |
Plazma-kallikrein inhibitorok
|
|
EP3139903B1
(en)
|
2014-05-07 |
2019-07-03 |
Croma-Pharma Gesellschaft m.b.H. |
Aqueous ophthalmic solution and method for treating dry eye syndrome
|
|
WO2015187997A1
(en)
*
|
2014-06-04 |
2015-12-10 |
Tersus Pharmaceuticals, LLC |
METHODS OF TREATING CHRONIC DRY EYE DISEASE USING C16:1n7 PALMITOLEATE AND DERIVATIVES THEREOF
|
|
US9463201B2
(en)
|
2014-10-19 |
2016-10-11 |
M.G. Therapeutics Ltd |
Compositions and methods for the treatment of meibomian gland dysfunction
|
|
WO2017055924A2
(en)
*
|
2015-09-28 |
2017-04-06 |
M.G. Therapeutics Ltd. |
Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
|
|
WO2017178892A2
(en)
*
|
2016-04-14 |
2017-10-19 |
M.G. Therapeutics Ltd. |
Selenium disulfide compositions for use in treating meibomian gland dysfunction
|
|
CA3020713A1
(en)
*
|
2016-04-19 |
2017-10-26 |
Azura Ophthalmics Ltd. |
Compositions for the treatment of hyperkeratosis disorders
|